Citation Impact
Citing Papers
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
2010 Standout
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
Astrocytes: biology and pathology
2009 Standout
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
2006 Standout
Brain metastases
2003
Enhanced T-Cell Responses to Glioma Cells Coated With the Anti-EGF Receptor Antibody and Targeted to Activating FcγRs on Human Dendritic Cells
2008 StandoutNobel
IDH1andIDH2Mutations in Gliomas
2009 Standout
Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy
2007
Genes that mediate breast cancer metastasis to the brain
2009 StandoutNature
Development of a model to predict permanent symptomatic postradiosurgery injury for arteriovenous malformation patients
2000
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
2013 Standout
Radiosurgery for brain metastases: is whole brain radiotherapy necessary?
1999
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials
1997 Standout
Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method
2001
A role for glutamate in growth and invasion of primary brain tumors
2008
Heterocyclic scaffolds as promising anticancer agents against tumours of the central nervous system: Exploring the scope of indole and carbazole derivatives
2014
Therapeutic Targeting of Histone Modifications in Adult and Pediatric High-Grade Glioma
2017
Imaging Changes after Stereotactic Radiosurgery of Primary and Secondary Malignant Brain Tumors
2002
Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: an analysis from Radiation Therapy Oncology Group Study 91-04
2001
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines
2007
Radiation Dose–Volume Effects in the Brain
2010
The golden age: gold nanoparticles for biomedicine
2011 Standout
Treatment of brain metastases in patients with non-small cell lung cancer (NSCLC) by stereotactic linac-based radiosurgery: prognostic factors
2002
Practice parameters for the management of single brain metastasis
2000
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
2013 Standout
Malignant Gliomas in Adults
2008 Standout
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
2015 Standout
Management of brain metastases
2004
Response criteria for glioma
2008
Radiotherapy for brain tumors
2000
Radiation Dose–Volume Effects in the Heart
2010
A New Prognostic Index and Comparison to Three Other Indices for Patients With Brain Metastases: An Analysis of 1,960 Patients in the RTOG Database
2007
Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases
2006 Standout
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Outcomes of Diffusion Tensor Tractography–Integrated Stereotactic Radiosurgery
2011
Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma
2014
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Pharmaceutical and therapeutic Potentials of essential oils and their individual volatile constituents: a review
2007 Standout
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial
2009 Standout
Honokiol: A Novel Natural Agent for Cancer Prevention and Therapy
2012 Standout
The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline
2009
Diagnosis and Treatment of High-Grade Astrocytoma
2007
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
2004 Standout
Management of glioblastoma: State of the art and future directions
2020 Standout
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
MRtrix: Diffusion tractography in crossing fiber regions
2012 Standout
Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
2008
Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science
2019 Standout
Management of brain metastases
2016
Drug delivery and nanoparticles: Applications and hazards
2008 Standout
Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box
2015 Standout
Diagnosis and Treatment of mela-noma Brain Metastasis: A Literature Review
2009
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects
2005 Standout
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
2010 Standout
Metastatic Behavior of Breast Cancer Subtypes
2010 Standout
Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial
2014 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
CNS Metastases in Breast Cancer
2004
Works of P.K. Sneed being referenced
Phase I/II trial of accelerated fractionation in brain metastases RTOG 85-28
1993
A phase II study of concurrent temozolomide and cis-retinoic acid with radiation for adult patients with newly diagnosed supratentorial glioblastoma
2005
A multi-institutional analysis of complication outcomes after arteriovenous malformation radiosurgery
1999
Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma
2011
Factors influencing survival after gamma knife radiosurgery for patients with single and multiple brain metastases.
2006
Diagnosis and Treatment of Recurrent High-Grade Astrocytoma
2006
48 Multi-institutional survival analysis of brain metastases patients treated with radiosurgery, stratified by RTOG RPA classification
1999
Radiosurgery for brain metastases from primary lung carcinoma.
2001
Number of brain metastases is not an important prognostic factor for survival following radiosurgery for newly-diagnosed nonmelanoma brain metastases
2003